According to literature, the research on mast cell-derived fibroblast growth factor (FGF2) mainly focuses on angiogenesis, fibrosis, wound healing, hypertension, kidney damage, airway hyperresponsiveness, chronic obstructive pulmonary disease, and other diseases (35–38). This evidence concerns the gene FGF2 and airway hyperresponsiveness.